Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › KYMR Leadership & Pay · Jun 8, 2026
Jeremy Chadwick, the Chief Operating Officer (COO) of Kymera Therapeutics, Inc., has announced his intention to… KYMR Kymera Therapeutics, Inc.
Jeremy Chadwick, the Chief Operating Officer (COO) of Kymera Therapeutics, Inc., has announced his intention to retirement and submitted his resignation as COO effective June 5, 2026. He will remain with the company as an advisor until November 2026. He resigned for personal reasons and not due to any disagreement with the company's practices or policies.
More from Kymera Therapeutics, Inc. Kymera reports $132.0M Q3 net loss and positive KT-579 Phase 1 data Oct 29, 2026 Kymera Therapeutics reported second quarter 2026 financial results, recognizing $65.0 million in collaboration revenue… Aug 5, 2026 Kymera Therapeutics, Inc. announced the retirement of Chief Medical Officer Jared Gollob, M.D., effective July 27… Jul 27, 2026 On June 25, 2026, Kymera Therapeutics announced the completion of enrollment for the global BROADEN2 Phase 2b trial of… Jun 25, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
